Mezigdomide and Multiple Myeloma
N Engl J Med
.
2023 Sep 14;389(11):1046-1050.
doi: 10.1056/NEJMe2307370.
Epub 2023 Aug 30.
Author
Jake Shortt
1
Affiliation
1
From the Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing, and Health Sciences, Monash University, and Monash Haematology, Monash Health - both in Clayton, VIC, Australia.
PMID:
37646699
DOI:
10.1056/NEJMe2307370
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Agents / therapeutic use
Humans
Multiple Myeloma* / drug therapy
Substances
Antineoplastic Agents